AbCellera Biologics Inc. ABCL Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s common stock, shares issued (in shares)?
- AbCellera Biologics Inc. (ABCL) reported common stock, shares issued (in shares) of $303.95M in Q1 2026.
- How has AbCellera Biologics Inc.'s common stock, shares issued (in shares) changed year-over-year?
- AbCellera Biologics Inc.'s common stock, shares issued (in shares) increased by 2.8% year-over-year, from $295.76M to $303.95M.
- What is the long-term trend for AbCellera Biologics Inc.'s common stock, shares issued (in shares)?
- Over 3 years (2022 to 2025), AbCellera Biologics Inc.'s common stock, shares issued (in shares) has grown at a 1.2% compound annual growth rate (CAGR), from $289.78M to $300.6M.